China Continuous Glucose Monitoring Devices Market Size (2024 - 2029)

The market size for continuous glucose monitoring devices in China is projected to experience significant growth over the forecast period. This expansion is driven by the increased demand for effective glycemic control solutions, particularly highlighted during the COVID-19 pandemic, which underscored the importance of monitoring blood glucose levels to prevent complications. The integration of innovative technologies, such as digital health apps and automated insulin management systems, is enhancing self-management capabilities for patients, thereby contributing to the market's growth. These advancements not only support diabetes care but also reduce the overall disease burden, further improving the market's potential.

Market Size of China Continuous Glucose Monitoring Devices Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
China Continuous Glucose Monitoring Devices Market Summary
Study Period 2018-2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 505.13 Million
Market Size (2029) USD 828.10 Million
CAGR (2024 - 2029) 10.39 %

Major Players

China Continuous Glucose Monitoring Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

China Continuous Glucose Monitoring Devices Market Analysis

The China Continuous Glucose Monitoring Devices Market size is estimated at USD 505.13 million in 2024, and is expected to reach USD 828.10 million by 2029, growing at a CAGR of 10.39% during the forecast period (2024-2029).

Maintaining good glycemic control during the COVID-19 pandemic was paramount to patients with diabetes mellitus. The deterioration of glycemic control led to chronic complications of diabetes mellitus and increased the risk of infection and associated mortality. Moreover, COVID-19 patients with uncontrolled type-2 diabetes had markedly higher mortality rates than those with good glycemic control. In addition, a few lab studies also suggested that the coronavirus had preferentially infected the insulin-producing beta cells. The SARS-CoV-2 infection led to reduced production and release of insulin from pancreatic islet tissue due to the death of some of the important beta cells, which led to diabetes in some people after suffering from acute COVID-19 infection. Thereby increasing the demand for continuous glucose monitoring devices to monitor and maintain optimum blood glucose levels.

Glucose monitoring increases patients’ awareness of glucose values, which supports healthy lifestyle choices. Blood glucose monitoring values help in providing feedback and guidance on how to make health behavior changes when needed. Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. Appropriate and timely Monitoring of blood glucose allows the successful management of out-of-range blood glucose levels, minimizing diabetic-related health complications.

Innovative technologies, such as digital health apps that display and summarize individual blood glucose measurements and incorporate additional relevant data, such as insulin doses, meals/snacks, and physical activity, can further support self-management while decreasing disease burden and benefitting overall diabetes care. Integration of blood glucose monitoring with insulin calculators, automated insulin titration software, and remote coaching are further developments that provide patients with poorly controlled diabetes additional support needed to improve critical outcomes, thereby enhancing the market prospects in the years to come.

China Continuous Glucose Monitoring Devices Industry Segmentation

Continuous glucose monitoring devices are used to diagnose both hyperglycemic and hypoglycemic conditions in diabetic patients throughout the day. The Chinese continuous glucose monitoring device market is segmented into components (sensors and durables). 

The report offers the value (in USD) and volume (in units) for the above segments.

Component
Sensors
Durables
Need A Different Region Or Segment?
Customize Now

China Continuous Glucose Monitoring Devices Market Size Summary

The China Continuous Glucose Monitoring Devices Market is poised for significant growth, driven by the increasing prevalence of diabetes and the need for effective glycemic control. The market is characterized by the adoption of advanced technologies that enhance self-management and reduce the burden of diabetes care. Continuous glucose monitoring (CGM) devices play a crucial role in managing blood glucose levels, thereby preventing complications associated with diabetes. The integration of digital health apps and innovative technologies, such as insulin calculators and automated insulin titration software, further supports patients in maintaining optimal health outcomes. The Chinese government's initiatives, including the Healthy China 2030 Plan, aim to control the prevalence of diabetes and improve self-management rates, contributing to the market's expansion.

The market is dominated by the sensors segment, which is expected to experience robust growth due to technological advancements aimed at improving accuracy and user-friendliness. Companies like Abbott, Medtronic, and Dexcom are at the forefront of innovation, investing in research and development to enhance their offerings. The introduction of non-invasive and minimally invasive glucose monitoring technologies, such as those developed by SIBIONICS and Know Labs, highlights the ongoing efforts to improve diabetes management solutions. As the diabetes population in China continues to grow, the demand for continuous glucose monitoring devices is anticipated to rise, supported by the country's strategic health policies and the increasing focus on chronic disease management.

Explore More

China Continuous Glucose Monitoring Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Component

      1. 2.1.1 Sensors

      2. 2.1.2 Durables

China Continuous Glucose Monitoring Devices Market Size FAQs

The China Continuous Glucose Monitoring Devices Market size is expected to reach USD 505.13 million in 2024 and grow at a CAGR of 10.39% to reach USD 828.10 million by 2029.

In 2024, the China Continuous Glucose Monitoring Devices Market size is expected to reach USD 505.13 million.

China Continuous Glucose Monitoring Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)